Pulmonary disease represents a significant extra-articular manifestation in the majority of
connective tissue diseases (CTDs). The identification, classification, and staging of …

Pulmonary disease is common in patients with connective tissue disease (CTD) and confers
significant morbidity and mortality. High-resolution computed tomography (HRCT) provides …

Connective tissue diseases (CTDs) comprise several immunologic systemic disorders, each
of which associated with a particular set of clinical manifestations and autoimmune profile …

Lung involvement is common in patients who have complications of connective tissue
disease (CTDs) and causes considerable morbidity and mortality. High resolution CT …

The majority of connective tissue diseases (CTDs) are multisystem disorders that are often
heterogeneous in their presentation and do not have a single laboratory, histologic, or …

Diffuse lung disease (DLD) is an important cause of pulmonary symptoms and is associated
with significant morbidity and mortality. The most common causes of DLD include idiopathic …

The term" connective tissue diseases"(CTDs) refers to a heterogeneous group of
autoimmune disorders, including systemic sclerosis, rheumatoid arthritis, Sjögren's …

There is a well-known association between the connective tissue disorders (CTDs) and lung
disease. In addition to interstitial lung disease, the CTDs may affect the air spaces and …

Connective tissue diseases (CTDs) are a common cause of chronic lung disease, and lung
involvement, which can be the initial site of disease, is a major contributor to CTD-related …

In this issue, you will find articles that review the pulmonary complications of connective
tissue disease (CTD), with the overwhelming focus on interstitial lung disease (ILD). Where it …